Biostage has promoted Saverio La Francesca, M.D. to president. Dr. La Francesca has served as Chief Medical Officer of the Company since April 2014. Prior to joining Biostage, Dr. La Francesca served in the department of cardiovascular surgery and transplantation at the DeBakey Heart and Vascular Center at the Houston Methodist Hospital.
Acuamark Diagnostics has recruited Dr. Michael Hanbury to its board of directors. Currently, Dr. Hanbury is a healthcare advisor for the Pritzker Group and is on a number of medical device company boards. Formerly, he was VP, laboratory operations and laboratory excellence for Quest Diagnostics, and Ppresident and chief operating officer at Solstas Lab Partners.
LightIntegra board has dubbed Bill Dubiel as president and CEO. He joins LightIntegra from Personal Genome Diagnostics, where he has been the chief commercial officer. He has held senior level positions at CyVek, Ventana, Roche, Bayer and Chiron Diagnostics.
Therachon has hired Dr. Maarten Kraan, Ph.D., M.D., chief medical officer. Most recently, Dr. Kraan was senior vice president, head of innovative medicines respiratory and inflammation at AstraZeneca. Prior to that, Dr. Kraan was vice president, head of clinical research and experimental development inflammation at Hoffman – La Roche. Before that, Dr. Kraan was vice president, immunosciences at Bristol Myers Squibb.